Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Tuesday, November 08, 2022
Insilico Medicine, a clinical stage artificial intelligence driven drug discovery company, announced a multi-year, multi-target strategic research collaboration with Sanofi. Under the terms of the agreement, the collaboration will leverage Insilico ...
read more
Thursday, November 10, 2022
Celerion is expanding its molecular and cellular capabilities to Good Laboratory Practice/Good Clinical Practice (GLP/GCP) standards to support the development of new gene and cell therapies.
read more
Monday, November 14, 2022
Mural Health Technologies announced the launch of its new platform, Mural Link, built to make it easy to participate in global clinical research studies.
read more
Monday, November 14, 2022
BioNTech announced its Singapore affiliate BioNTech Pharmaceuticals Asia Pacific entered into an agreement with Novartis Singapore Pharmaceutical Manufacturing to acquire one of its GMP-certified manufacturing facilities. Supported by the Singapore ...
read more
Tuesday, November 15, 2022
NorthStar Medical Radioisotopes announced a significant expansion of its business platform with the formation of a new, patient-focused Radiopharmaceutical Contract Development and Manufacturing Organization (CDMO) services unit.
read more
Tuesday, November 15, 2022
Almac Group announced that after the successful pre-approval inspection (PAI) of its Pharma Services’ operations located in Audubon, Pennsylvania by the FDA, the site has received product approval from the US FDA, UK Medicines and Healthcare products...
read more
Wednesday, November 16, 2022
QPS recently opened a second preclinical research facility in Taipei, Taiwan. The 2,793-square-foot facility will facilitate a research expansion into additional toxicology studies and a newly launched capability in pharmacology studies.
read more
Wednesday, November 16, 2022
Viz.ai, a provider of AI-powered disease detection and intelligent care coordination, announced a strategic partnership with Vastrax, a full-service, vascular clinical research organization (CRO).
read more
Wednesday, November 16, 2022
MilliporeSigma is investing more than $ 286 million in its biosafety testing capacity at the company’s site in Rockville, Maryland, USA. This will significantly increase the company’s ability to conduct biosafety testing and analytical development ...
read more
Thursday, November 17, 2022
Piramal Critical Care (PCC) has integrated its sustainability framework with its strategy as well as daily business practices.
read more
Thursday, November 17, 2022
GE Healthcare’s Pharmaceutical Diagnostics business announced an $80 million investment to increase manufacturing capacity by 30 percent at its Active Pharmaceutical Ingredients (API) site in Lindesnes, Norway.
read more
Friday, November 18, 2022
Albert Labs International Corp. has signed a Letter of Intent (LOI) with full-service Contract-Research Organization (CRO), iNGENu, to carry out the Company's first in-human study of its primary drug target, KRN-101.
read more
Monday, November 21, 2022
Rentschler Biopharma, a leading global contract development and manufacturing organization (CDMO) for biopharmaceuticals, announced, that following seven years of accelerated growth at Rentschler Biopharma under his leadership as Chief Executive ...
read more
Monday, November 21, 2022
Cambrex entered an agreement to acquire Snapdragon Chemistry, a leading US-based provider of chemical process development services to a broad range of emerging and established biopharma customers.
read more
Tuesday, November 22, 2022
FUJIFILM Corporation announced a $188 million investment to establish a cell culture media manufacturing facility in Research Triangle Park (RTP), North Carolina, USA. The new site will be operated by FUJIFILM Irvine Scientific,
read more